Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection

Journal of Medical Virology

Volumn 86, Issue 5, 2014, Pages 886-894

  Liu, Jing ^a   Wu, Jianqi ^b   Wang, Bing ^c   Zeng, Sheng ^a   Qi, Feifei ^a   Lu, Changlong ^a   Kimura, Yoshinobu ^d   Liu, Beixing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d GIFU UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Constructed DNA vaccine; Influenza; Liposome; Oral vaccination; Protective immunity

Indexed keywords

COMPLEMENTARY DNA; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; LIPOSOME; PLASMID DNA; PROTEIN; PROTEIN M1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; ENCAPSULATION; EXPRESSION VECTOR; GASTROINTESTINAL TRACT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; SPLEEN; VIRUS NEUTRALIZATION;

EUKARYOTA; INFLUENZA A VIRUS; MUS;

CONSTRUCTED DNA VACCINE; INFLUENZA; LIPOSOME; ORAL VACCINATION; PROTECTIVE IMMUNITY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; INFLUENZA VACCINES; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LIPOSOMES; MALE; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, DNA; VIRAL MATRIX PROTEINS;

EID: 84895918110     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23768     Document Type: Article

References (43)

1. Banner D, Kelvin AA. 2012. The current state of H5N1 vaccines and the use of the ferret model for influenza therapeutic and prophylactic development. J Infect Dev Ctries 6:465-469.
2. Channarong S, Chaicumpa W, Sinchaipanid N, Mitrevej A. 2011. Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: The improvement of Peyer's patch targeting using a polyplex-loaded liposomes. AAPS Pharm Sci Tech 12:192-200.
3. Dégano P, Schneider J, Hannan CM, Gilbert SC, Hill AV. 1999. Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: Enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models. Vaccine 18:623-632.
4. Durando P, Iudici R, Alicino C, Alberti M, de Florentis D, Ansaldi F, Icardi G. 2011. Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine. Hum Vaccin 7:29-40.
5. Epstein SL, Stack A, Misplon JA, Lo CY, Mostowski H, Bennink J, Subbarao K. 2000. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: Either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge. Int Immunol 12:91-101.
6. Epstein SL, Tumpey TM, Misplon JA, Lo CY, Cooper LA, Subbarao K, Renshaw M, Sambhara S, Katz JM. 2002. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerg Infect Dis 8:796-801.
7. Felnerova D, Viret JF, Glck R, Moser C. 2004. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr Opin Biotechnol 15:518-529.
8. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ, Centers for Disease Control and Prevention. 2010. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59:1-62.
9. Gavazzi G, Krause KH. 2002. Ageing and infection. Lancet Infect Dis 2:659-666.
10. Gregoriadis G, Gursel I, Gursel M, McCormack B. 1996. Liposome as immunological adjuvants and vaccine carrier. J Control Release 41:49-56.
11. Heinen PP, Rijsewijk FA, de Boer-Luijtze EA, Bianchi AT. 2002. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J Gen Virol 83:1851-1859.
12. Ichinohe T, Ainai A, Ami Y, Nagata N, Iwata N, Kawaguchi A, Suzaki Y, Odagiri T, Tashiro M, Takahashi H, Strayer DR, Carter WA, Chiba J, Tamura S, Sata T, Kurata T, Hasegawa H. 2010. Intranasal administration of adjuvant-combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus. J Med Virol 82:1754-1761.
13. Irie T, Watarai S, Kodama H. 2003. Humoral immune response of carp (Cyprinus carpio) induced by oral immunization with liposome-entrapped antigen. Dev Comp Immunol 27:413-421.
14. Irie T, Watarai S, Iwasaki T, Kodama H. 2005. Protection against experimental Aeromonas salmonicida infection in carp by oral immunization with bacterial antigen entrapped liposomes. Fish Shellfish Immunol 18:235-242.
15. Ivanovska N, Tchorbanov A, Prechl J, Maximova V, Voynova E, Vassilev TL. 2006. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus. Vaccine 24:1830-1837.
16. Johnson PA, Conway MA, Daly J, Nicolson C, Robertson J, Mills KH. 2000. Plasmid DNA encoding influenza virus hemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J Gen Virol 81:1737-1745.
17. Jones A, Bosio C, Duffy A, Goodyear A, Schriefer M, Dow S. 2010. Protection against pneumonic plague following oral immunization with a non-replicating vaccine. Vaccine 28:5924-5929.
18. Kantele A, Häkkinen M, Moldoveanu Z, Lu A, Savilahti E, Alvarez RD, Michalek S, Mestecky J. 1998. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun 66:5630-5635.
19. Kim JH, Jacob J. 2009. DNA vaccines against influenza viruses. Curr Top Microbiol Immunol 333:197-210.
20. Klotz C, Gehre F, Lucius R, Pogonka T. 2007. Identification of Eimeria tenella genes encoding for secretory proteins and evaluation of candidates by DNA immunization studies in chickens. Vaccine 25:6625-6634.
21. Kodihalli S, Kobasa DL, Webster RG. 2000. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Vaccine 18:2592-2599.
22. Ledgerwood JE, Hu Z, Gordon IJ, Yamshchikov G, Enama ME, Plummer S, Bailer R, Pearce MB, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS. VRC 304 and VRC 305 Study Teams. 2012. Influenza virus H5 DNA influenza vaccination is immunogenic by intramuscular and intradermal routes in humans. Clin Vaccine Immunol 19:1792-1797.
23. Lewis DJ, Castello-Branco LR, Novotny P, Dougan G, Poulton TA, Griffin GE. 1993. Circulating cellular immune response to oral immunization of humans with cholera toxin B-subunit. Vaccine 11:119-121.
24. Li J, Huang Y, Liang X, Lu M, Li L, Yu L, Deng R. 2003. Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: Factors influencing efficacy. Virus Res 98:63-74.
25. Liu B, Mori I, Hossain MJ, Dong L, Kimura Y. 2001. Peroral vaccination with a temperature-sensitive mutant of parainfluenza virus type 1 protects mice against respiratory challenge infection. J Gen Virol 82:2889-2894.
26. McDermott MR, Bienenstock J. 1979. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol 122:1892-1898.
27. Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W. 1999. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5:1157-1163.
28. Okuda K, Ihata A, Watabe S, Okada E, Yamakawa T, Hamajima K, Yang I, Ishii N, Nakazawa M, Okuda K, Ohnari K, Nakajima K, Xin KQ. 2001. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Vaccine 19:3681-3691.
29. Ozaki T, Yauchi M, Xin KQ, Hirahara F, Okuda K. 2005. Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant. Viral Immunol 18:373-380.
30. Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC. 2011. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e. Vaccine 29:5481-5487.
31. Reed L, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497.
32. Reuman PD, Keely SP, Schiff GM. 1990. Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus. J Med Virol 32:67-72.
33. Singh P, Prabakaran D, Jain S, Mishra V, Jaganathan KS, Vyas SP. 2004. Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int J Pharm 278:379-390.
34. Szécsi J, Gabriel G, Edfeldt G, Michelet M, Klenk HD, Cosset FL. 2009. DNA vaccination with a single-plasmid construct coding for viruslike particles protects mice against infection with a highly pathogenic avian influenza A virus. J Infect Dis 200:181-190.
35. Takamura S, Niikura M, Li TC, Takeda N, Kusagawa S, Takebe Y, Miyamura T, Yasutomi Y. 2004. DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration. Gene Ther 11:628-635.
36. Thueng-in K, Maneewatch S, Srimanote P, Songserm T, Tapchaisri P, Sookrung N, Tongtawe P, Channarong S, Chaicumpa W. 2010. Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines. Vaccine 28:6765-6777.
37. Torrieri-Dramard L, Lambrecht B, Ferreira HL, Van den Berg T, Klatzmann D, Bellier B. 2011. Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses. Mol Ther 19:602-611.
38. Vanrompay D, Cox E, Vandenbussche F, Volckaert G, Goddeeris B. 1999. Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations. Vaccine 17:2628-2635.
39. Wang J, Murakami T, Yoshida S, Matsuoka H, Ishii A, Tanaka T, Tobiya K, Ohtsuki M, Nakagawa H, Kusama M, Kobayashi E. 2003. Predominant cell-mediated immunity in the oral mucosa: Gene gun-based vaccination against infectious diseases. J Dermatol Sci 31:203-210.
40. Yager EJ, Dean HJ, Fuller DH. 2009. Prospects for developing an effective particle-mediated DNA vaccine against influenza. Expert Rev Vaccine 8:1205-1220.
41. Yeh P, Ellens H, Smith PL. 1998. Physiological considerations in the design of particulate dosage forms for oral vaccine delivery. Adv Drug Deliv Rev 34:123-133.
42. Yuki Y, Kiyono H. 2009. Mucosal vaccines: Novel advances in technology and delivery. Expert Rev Vaccines 8:1083-1097.
43. Zhirnov OP, Isaeva EI, Konakova TE, Thoidis G, Piskareva LM, Akopova II, Kartashov A, Altstein AD, Llyinskii PO, Shneeider AM. 2007. Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1. Influenza Other Respir Viruses 1:71-79.